Announcements Trials
Browse Landscape

Status

Recruiting 5Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Observational 6Interventional 3

Sponsor

Cancer Type

Myeloid 6Other hematologic neoplasm 1

Conditions

Neoplasms 271Breast Neoplasms 264Lung Neoplasms 130Prostatic Neoplasms 114Colorectal Neoplasms 108Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 51Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 49Urinary Bladder Neoplasms 47Brain Neoplasms 45Melanoma 42Leukemia, Myeloid, Acute 42Head and Neck Neoplasms 40Esophageal Neoplasms 40Colonic Neoplasms 38Disease 37Liver Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Rectal Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Recurrence 28Kidney Neoplasms 28Uterine Cervical Neoplasms 27

Interventions

avapritinib 1Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Mastocytosis × 90 days × Clear all
NCT00044122 2026-06-05

Study of Factors Regulating Mast Cell Proliferation

National Institutes of Health Clinical Center (CC)

Recruiting
600 enrolled
Myeloid

Mastocytosis

NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

NCT06186856 2026-04-22

DATAMAST

Imagine Institute

Recruiting
13,000 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT07264959 2026-04-22

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Blueprint Medicines Corporation

Recruiting
150 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT07255638 2026-04-20

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Blueprint Medicines Corporation

Recruiting
80 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT02450396 2026-03-27

EGR2

Assistance Publique - Hôpitaux de Paris

Withdrawn
Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡